Search Results 131-140 of 1033 for 香港搜尋引擎平臺 🔍 www.7.hk.cn

  1. A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors - Mayo Clinic

    The purpose of this study is to determine the safety and tolerability profile of a single dose of AdAPT-001 in subjects with advanced solid tumors that have ...

  2. A Study to Evaluate the Effectiveness and Safety of Vibegron Administered Orally for 12 Weeks to Women with Irritable Bowel Syndrome - Mayo Clinic

    Search. Request an Appointment · Find a ... Search. Search. All Mayo Clinic Topics. Care at Mayo ... IBS-D: loose, mushy, or watery stools (Bristol Type 6 or 7) ...

  3. Publications - Xiaoning Ding, Ph.D. - Mayo Clinic

    2010 Oct; 37(10):5442-7. View PubMed; Arjomandy B, Sahoo N, Zhu XR, Zullo JR, Wu RY, Zhu M, Ding X, Martin C, Ciangaru G, Gillin MT. An overview of the ...

  4. A Trial of TTI-621 for Patients With Hematologic Malignancies and Selected Solid Tumors - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. Han W. Tun, M.D. - Doctors and Medical Staff - Mayo Clinic

    ... suggestion or enter key to search with the suggestion.Search by keyword or phrase. Search. Search for a doctor. Han W. Tun, M.D.. Hematologist; Internist ...

  6. A Study Comparing BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM) - Mayo Clinic

    This study is to evaluate the safety, efficacy and clinical benefit of BGB-3111 vs ibrutinib in subjects with MYD88 Mutation Waldenström's Macroglobulinemia.

  7. A Study to Evaluate the Effectiveness, Safety, Pharmacokinetics and Pharmacodynamics of Idasanutlin Monotherapy in Participants With Hydroxyurea-Resistant/Intolerant Polycythemia Vera - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness of idasanutlin monotherapy in participants with hydroxyurea (HU)-resistant/intolerant ...

  8. A Study Using the New TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients with Metastatic, Persistent, Recurrent, or Progressive Solid Tumors - Mayo Clinic

    About this study. This phase Ib trial studies the best way of TLR8 Agonist VTX-2337 and cyclophosphamide in treating patients with a solid tumor that has ...

  9. Match Day 2019: Celebrating a Day of Destiny - News Archive - Mayo Clinic College of Medicine & Science

    14 percent, emergency medicine; 7 percent, dermatology; 5 percent, anesthesiology; 5 percent, neurology/pediatric neurology; 5 percent, OB-GYN; 2 percent, ...

  10. Characterization of Orthobiologic Agents Used for Point of Care Ultrasound Guided Procedures and Associated Outcomes - Mayo Clinic

    About this study. The purpose of this study is to determine patient and manufacturing factors that influence orthobiologic agent (OBA) product components ...